The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes

Diabetologia

Volumn 58, Issue 1, 2015, Pages 10-18

  Narendran, Parth ^a,b   Solomon, Thomas P ^c   Kennedy, Amy ^a,b   Chimen, Myriam ^a   Andrews, Rob C ^d,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

Beta cell; Exercise; Immune intervention; Type 1 diabetes

Indexed keywords

EXENDIN 4; GEVOKIZUMAB; GLUCOSE; INSULIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STREPTOZOCIN;

APOPTOSIS; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; CONTROLLED STUDY; DIABETIC PATIENT; EDITORIAL; EXERCISE; FAT MASS; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; ORGAN PRESERVATION; PANCREAS ISLET BETA CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CELL COUNT; CELL PROTECTION; CYTOLOGY; DIABETES MELLITUS, TYPE 1; KINESIOTHERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL COUNT; CYTOPROTECTION; DIABETES MELLITUS, TYPE 1; EXERCISE; EXERCISE THERAPY; HUMANS; INSULIN-SECRETING CELLS;

EID: 84916607677     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3412-8     Document Type: Editorial

References (68)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221–229
2. Sherry NA, Tsai EB, Herold KC (2005) Natural history of beta-cell function in type 1 diabetes. Diabetes 54(Suppl 2):S32–S39
3. Oram RA, Jones AG, Besser REJ et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187–191
4. Steffes MW, Sibley S, Jackson M, Thomas W (2003) Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26:832–836
5. von Herrath M, Peakman M, Roep B (2013) Progress in immune-based therapies for type 1 diabetes. Clin Exp Immunol 172:186–202
6. Kroll JL, Beam C, Li S et al (2013) Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol 57:115–119
7. Keymeulen B, Candon S, Fafi-Kremer S et al (2010) Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. Blood 115:1145–1155
8. Ben Nasr M, D’Addio F, Usuelli V et al (2014) The rise, fall, and resurgence of immunotherapy in type 1 diabetes. Pharmacol Res. doi:10.1016/j.phrs.2014.07.004
9. Nielsen JH, Linde S, Welinder BS et al (1989) Growth hormone is a growth factor for the differentiated pancreatic beta-cell. Mol Endocrinol 3:165–173
10. Jensen J, Galsgaard ED, Karlsen AE et al (2005) STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production. J Endocrinol 187:25–36
11. Choi SB, Jang JS, Hong SM et al (2006) Exercise and dexamethasone oppositely modulate beta-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol 190:471–482
12. Park S, Hong SM, Lee JE, Sung SR (2007) Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic beta-cell function and mass through IRS2 in diabetic rats. J Appl Physiol 103:1764–1771
13. Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481–1489
14. Ronsen O, Lea T, Bahr R, Pedersen BK (2002) Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes. J Appl Physiol (1985) 92:2547–2553
15. Steensberg A, Fischer CP, Keller C et al (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:E433–E437
16. Moran A, Bundy B, Becker DJ et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381:1905–1915
17. Cavelti-Weder C, Babians-Brunner A, Keller C et al (2012) Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes. Diabetes Care 35:1654–1662
18. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85–97
19. Ben Ounis O, Elloumi M, Lac G et al (2009) Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents. Ann Endocrinol (Paris) 70:235–241
20. Pang TTL, Chimen M, Goble E et al (2013) Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab 98:E418–E428
21. Oliveira M, Gleeson M (2010) The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur J Appl Physiol 109:251–257
22. Gleeson M, McFarlin B, Flynn M (2006) Exercise and Toll-like receptors. Exerc Immunol Rev 12:34–53
23. Karstoft K, Winding K, Knudsen SH et al (2013) The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 36:228–236
24. Solomon TPJ, Haus JM, Marchetti CM et al (2009) Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 297:E552–E559
25. Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744
26. Garvey WT, Olefsky JM, Griffin J et al (1985) The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 34:222–234
27. Hojberg PV, Zander M, Vilsboll T et al (2008) Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes. Diabetologia 51:632–640
28. Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295–1299
29. Elks ML (1993) Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208–214
30. Piro S, Anello M, Di Pietro C et al (2002) Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metab Clin Exp 51:1340–1347
31. Strom A, Kolb H, Martin S et al (2012) Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). PLoS One 7:e33108
32. Coskun O, Ocakci A, Bayraktaroglu T, Kanter M (2004) Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 203:145–154
33. Huang H-H, Farmer K, Windscheffel J et al (2011) Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Exp Diabetes Res 2011:481427
34. Shima K, Zhu M, Noma Y et al (1997) Exercise training in Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous non-insulin-dependent diabetes mellitus: effects on the B-cell mass, insulin content and fibrosis in the pancreas. Diabetes Res Clin Pract 35:11–19
35. Pold R, Jensen LS, Jessen N et al (2005) Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54:928–934
36. Király MA, Bates HE, Yue JTY et al (2007) Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metab Clin Exp 56:732–744
37. Király MA, Bates HE, Kaniuk NA et al (2008) Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 294:E271–E283
38. Delghingaro-Augusto V, Decary S, Peyot M-L et al (2012) Voluntary running exercise prevents beta-cell failure in susceptible islets of the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab 302:E254–E264
39. Laker RC, Gallo LA, Wlodek ME et al (2011) Short-term exercise training early in life restores deficits in pancreatic beta-cell mass associated with growth restriction in adult male rats. Am J Physiol Endocrinol Metab 301:E931–E940
40. Kruszynska YT, Home PD, Hanning I, Alberti KG (1987) Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 30:16–21
41. Palmer JP, Fleming GA, Greenbaum CJ et al (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 53:250–264
42. Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26:1198–1203
43. Dalla Man C, Campioni M, Polonsky KS et al (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54:3265–3273
44. Slentz CA, Tanner CJ, Bateman LA et al (2009) Effects of exercise training intensity on pancreatic beta-cell function. Diabetes Care 32:1807–1811
45. Boule NG, Weisnagel SJ, Lakka TA et al (2005) Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28:108–114
46. Bloem CJ, Chang AM (2008) Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab 93:387–392
47. Malin SK, Solomon TPJ, Blaszczak A et al (2013) Pancreatic beta-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. Am J Physiol Endocrinol Metab 305:E1248–E1254
48. Reitman JS, Vasquez B, Klimes I, Nagulesparan M (1984) Improvement of glucose homeostasis after exercise training in non-insulin-dependent diabetes. Diabetes Care 7:434–441
49. Krotkiewski M, Lonnroth P, Mandroukas K et al (1985) The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 28:881–890
50. Trovati M, Carta Q, Cavalot F et al (1984) Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7:416–420
51. Michishita R, Shono N, Kasahara T, Tsuruta T (2008) Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus. Diabetes Res Clin Pract 82:291–297
52. Solomon TPJ, Haus JM, Kelly KR et al (2010) Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 33:1561–1566
53. Dela F, von Linstow ME, Mikines KJ, Galbo H (2004) Physical training may enhance beta-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287:E1024–E1031
54. Solomon TPJ, Malin SK, Karstoft K et al (2013) Pancreatic beta-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab 98:4176–4186
55. Kahleova H, Mari A, Nofrate V et al (2012) Improvement in beta-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications 26:442–449
56. Burns N, Finucane FM, Hatunic M et al (2007) Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 50:1500–1508
57. Dabelea D, Mayer-Davis EJ, Andrews JS et al (2012) Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 55:3359–3368
58. Maclaren N, Lan M, Coutant R et al (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12:279–287
59. Cutovic M, Konstantinovic L, Stankovic Z, Vesovic-Potic V (2012) Structured exercise program improves functional capacity and delays relapse in euthyroid patients with Graves’ disease. Disabil Rehabil 34:1511–1518
60. Naldi L, Conti A, Cazzaniga S et al (2014) Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol 170:634–642
61. Dalgas U, Stenager E (2012) Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord 5:81–95
62. Chimen M, Kennedy A, Nirantharakumar K et al (2012) What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia 55:542–551
63. Galassetti P, Riddell MC (2013) Exercise and type 1 diabetes (T1DM). Compr Physiol 3:1309–1336
64. Tielemans SMAJ, Soedamah-Muthu SS, de Neve M et al (2013) Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 56:82–91
65. Brazeau A-S, Rabasa-Lhoret R, Strychar I, Mircescu H (2008) Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31:2108–2109
66. Kahn SE, Larson VG, Beard JC et al (1990) Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 258:E937–E943
67. Pratley RE, Hagberg JM, Dengel DR et al (2000) Aerobic exercise training-induced reductions in abdominal fat and glucose-stimulated insulin responses in middle-aged and older men. J Am Geriatr Soc 48:1055–1061
68. Dela F, Stallknecht B (2010) Effect of physical training on insulin secretion and action in skeletal muscle and adipose tissue of first-degree relatives of type 2 diabetic patients. Am J Physiol Endocrinol Metab 299:E80–E91